Charng-Ming Huang

Title: Charng-Ming Huang: Innovator in Antimicrobial Peptides

Introduction

Charng-Ming Huang is a notable inventor based in Bethesda, MD (US). He has made significant contributions to the field of antimicrobial peptides, particularly through his innovative research and patent work. His expertise lies in designing and synthesizing peptides that exhibit improved antimicrobial activity.

Latest Patents

Huang holds a patent for "Antimicrobial magainin modified peptides." This patent describes peptides that are designed and synthesized based on the sequences of magainin or PGS peptides. The modified peptide analogues are created by replacing low helical potential amino acid residues with high helical potential residues. Additionally, modifications to the termini enhance the amphiphilic structures and prolong antimicrobial activity by reducing susceptibility to protease degradation. For instance, residues such as Ser.sup.8, Gly.sup.13, and Gly.sup.18 are modified to improve their helical potential. The resulting modified peptides exhibit an increase in antimicrobial activity by up to two orders of magnitude, while maintaining low hemolytic activity compared to magainin 1.

Career Highlights

Huang's career is marked by his work with the United States of America as Represented by the Department of Health. His research has focused on the development of peptides that can effectively combat microbial infections, showcasing his commitment to advancing healthcare solutions.

Collaborations

Huang has collaborated with notable colleagues, including Judith H Brown and John L Morell. These collaborations have contributed to the advancement of his research and the successful development of his patented peptides.

Conclusion

Charng-Ming Huang's innovative work in antimicrobial peptides has the potential to significantly impact the field of medicine. His research not only enhances our understanding of peptide design but also offers promising solutions for combating microbial infections.